102 related articles for article (PubMed ID: 36693840)
1.
Laczko D; Poveda-Rogers C; Matthews AH; Snaith O; Luger S; Bagg A; Caponetti GC; Morrissette JJD; Yang G
Leuk Lymphoma; 2024 Mar; ():1-7. PubMed ID: 38506144
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial genetics reveals the Dock1-Rac2 axis as a potential target for the treatment of NPM1;Cohesin mutated AML.
Meyer AE; Stelloh C; Pulakanti K; Burns R; Fisher JB; Heimbruch KE; Tarima S; Furumo Q; Brennan J; Zheng Y; Viny AD; Vassiliou GS; Rao S
Leukemia; 2022 Aug; 36(8):2032-2041. PubMed ID: 35778533
[TBL] [Abstract][Full Text] [Related]
3. Cohesin mutations are synthetic lethal with stimulation of WNT signaling.
Chin CV; Antony J; Ketharnathan S; Labudina A; Gimenez G; Parsons KM; He J; George AJ; Pallotta MM; Musio A; Braithwaite A; Guilford P; Hannan RD; Horsfield JA
Elife; 2020 Dec; 9():. PubMed ID: 33284104
[TBL] [Abstract][Full Text] [Related]
4. STAG2 mutations regulate 3D genome organization, chromatin loops, and Polycomb signaling in glioblastoma multiforme.
Xu W; Kim JS; Yang T; Ya A; Sadzewicz L; Tallon L; Harris B; Sarkaria J; Jin F; Waldman T
J Biol Chem; 2024 May; ():107341. PubMed ID: 38705393
[TBL] [Abstract][Full Text] [Related]
5. Chromatin organization in myelodysplastic syndrome.
Xu JJ; Viny AD
Exp Hematol; 2024 Apr; 134():104216. PubMed ID: 38582293
[TBL] [Abstract][Full Text] [Related]
6. Correction to: Morphologic, immunophenotypic, molecular genetic, and clinical characterization in patients with SRSF2-mutated acute myeloid leukemia.
Am J Clin Pathol; 2023 Nov; 160(5):544. PubMed ID: 37748199
[No Abstract] [Full Text] [Related]
7. Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics.
Santoro N; Salutari P; Di Ianni M; Marra A
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673842
[TBL] [Abstract][Full Text] [Related]
8. The consequences of cohesin mutations in myeloid malignancies.
Bhattacharya SA; Dias E; Nieto-Aliseda A; Buschbeck M
Front Mol Biosci; 2023; 10():1319804. PubMed ID: 38033389
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial.
Kubasch AS; Peterlin P; Cluzeau T; Götze KS; Sockel K; Teipel R; Jentzsch M; Attalah H; Sebert M; Chermat F; Gloaguen S; Puttrich M; Cross M; Schneider M; Kayser S; Schipp D; Giagounidis A; Tirado-Gonzalez I; Descot A; van de Loosdrecht A; Weigert A; Metzeler KH; Fenaux P; Medyouf H; Platzbecker U; Ades L
Leukemia; 2023 Nov; 37(11):2309-2313. PubMed ID: 37735558
[No Abstract] [Full Text] [Related]
10. Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias.
Testa U; Pelosi E; Castelli G
Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509445
[TBL] [Abstract][Full Text] [Related]
11. Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022.
Bouligny IM; Maher KR; Grant S
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444402
[TBL] [Abstract][Full Text] [Related]
12. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome.
Eckardt JN; Stasik S; Röllig C; Sauer T; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Hanoun M; Kaiser U; Kaufmann M; Rácil Z; Mayer J; Cerqueira T; Kroschinsky F; Berdel WE; Serve H; Müller-Tidow C; Platzbecker U; Baldus CD; Schetelig J; Siepmann T; Bornhäuser M; Middeke JM; Thiede C
Blood Cancer J; 2023 Jan; 13(1):18. PubMed ID: 36693840
[TBL] [Abstract][Full Text] [Related]
13. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.
Thol F; Bollin R; Gehlhaar M; Walter C; Dugas M; Suchanek KJ; Kirchner A; Huang L; Chaturvedi A; Wichmann M; Wiehlmann L; Shahswar R; Damm F; Göhring G; Schlegelberger B; Schlenk R; Döhner K; Döhner H; Krauter J; Ganser A; Heuser M
Blood; 2014 Feb; 123(6):914-20. PubMed ID: 24335498
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations of the cohesin complex genes in myeloid malignancies.
Thota S; Viny AD; Makishima H; Spitzer B; Radivoyevitch T; Przychodzen B; Sekeres MA; Levine RL; Maciejewski JP
Blood; 2014 Sep; 124(11):1790-8. PubMed ID: 25006131
[TBL] [Abstract][Full Text] [Related]
16. Cohesin gene mutations in tumorigenesis: from discovery to clinical significance.
Solomon DA; Kim JS; Waldman T
BMB Rep; 2014 Jun; 47(6):299-310. PubMed ID: 24856830
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive genomic profiling reveals molecular subsets of
Johnson SM; Haberberger J; Galeotti J; Ramkissoon L; Coombs CC; Richardson DR; Foster MC; Duncan D; Montgomery ND; Ferguson NL; Zeidner JF
Leuk Lymphoma; 2024 Feb; 65(2):209-218. PubMed ID: 37921062
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
